Sensei Biotherapeutics (NASDAQ:SNSE) Trading Up 0.2% – Here’s Why

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) was up 0.2% on Thursday . The stock traded as high as $0.49 and last traded at $0.48. Approximately 117,935 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 670,276 shares. The stock had previously closed at $0.48.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $4.00 price objective on shares of Sensei Biotherapeutics in a research note on Wednesday, January 8th.

Sensei Biotherapeutics Trading Up 1.8 %

The firm has a market capitalization of $12.29 million, a price-to-earnings ratio of -0.41 and a beta of 0.17. The company has a fifty day moving average price of $0.49 and a two-hundred day moving average price of $0.53.

Institutional Investors Weigh In On Sensei Biotherapeutics

An institutional investor recently raised its position in Sensei Biotherapeutics stock. National Bank of Canada FI grew its stake in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) by 355.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 45,575 shares of the company’s stock after acquiring an additional 35,575 shares during the period. National Bank of Canada FI owned about 0.18% of Sensei Biotherapeutics worth $27,000 as of its most recent filing with the SEC. 10.50% of the stock is owned by hedge funds and other institutional investors.

About Sensei Biotherapeutics

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.